The maker of bone graft material and antimicrobial coatings for medical applications will present on June 7th at 11:00AM (NYSE:ET), at the Jefferies 2012 Global Healthcare Conference, in New York, New York.
Bacterin's presentation will be webcast and available online at www.investor.bacterin.com.
The company recently unveiled, at the beginning of May, its third national group purchasing organization (GPO) contract, announcing a three-year agreement with health care supply chain company Novation.
The agreement provides Bacterin's full biologic portfolio to the nationwide network of hospitals and medical practices served by Novation.
The portfolio includes Bacterin's OsteoSponge, OsteoSelect DBM Putty, OsteoWrap, OsteoLock, BacFast, hMatrix, Sports Medicine Allografts, and traditional allografts.
Bacterin's technology optimizes the growth factors in human allografts to promote bone, subchondral repair and dermal growth.
The company's products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, bone growth in foot and ankle surgery, cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries.